Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Piwi-like RNA-mediated gene silencing 3 (PIWIL3) is a protein-coding gene belonging to the PIWI subfamily of the Argonaute protein family, characterized by the presence of PAZ and Piwi domains[1][7][8]. It is primarily involved in the maintenance of germline cells, functioning through the piRNA metabolic process to repress transposable elements during meiosis, thereby preserving genomic stability[1][6][8]. PIWIL3 directly binds to piRNAs—a class of 24–30 nucleotide RNAs derived mostly from transposable elements and repeat sequences—which facilitate DNA methylation and sequence-specific silencing of transposons[1][8]. Besides transposon repression, PIWIL3 is believed to regulate translation and participate in other meiotic processes[8]. Expression of PIWIL3 has been associated with certain cancers, including lung cancer, where it may promote tumor progression[3], and defects in this gene have been linked to male infertility[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Piwi-like RNA-mediated gene silencing 3 (PIWIL3).